The usage of medications for hospice care related to pain, anxiety, nausea or otherwise is not new and it is not novel. However, what is new is the ability to compound these drugs with SubMagna™ HMW, to enable delivery in a sublingual (under the tongue) dosage form that can also be swallowed. To learn more about this SubMagna™ HMW base, review the information found at www.submagna.com.

When dealing with patients on hospice care, there are a lot of things to consider. Most hospice patients are on pain medications which result in constipation and dryness of mouth (among other side effects.) SubMagna™ HMW can be used to deliver nausea medications, such as Ondansetron. Additionally, SubMagna™ HMW can be used to delivery anti-anxiety medications, such as Lorazepam, in a sublingual anhydrous suspension. Both of these medications could have Docusate Sodium or other stool softeners added to the compound to assist the patient. From the experiences of those providing care in this arena, almost every patient on hospice care will have constipation as an issue, and the addition of docusate sodium could be beneficial.

By compounding with SubMagna™ HMW as the base, a patient can have his/her dosage changed without ever having to go back to the pharmacy to obtain a different strength. The volume of the dose taken can simply be increased or decreased, when necessary, as prescribed. This is fundamentally easier for the patient, for the prescriber and for the pharmacy.

If you’re looking for a compounding base to deliver medications in a sublingual format that can be absorbed through the mucosal tissue in the oral cavity, or in the stomach, that enables a change in dosage without the necessity of making a new compound, look no further than SubMagna™ HMW.